Related Experiment Video
Updated: May 29, 2026

Amplitude-Integrated EEG in Infants at Risk of Hypoxic-Ischemic Encephalopathy: A Feasibility Study in Road and Air Transport in Western Australia
Published on: June 21, 2024
United Kingdom national paediatric bilateral audit
H E Cullington1, D Bele, J C Brinton
1South of England Cochlear Implant Centre, Institute of Sound and Vibration Research, University of Southampton, Southampton, UK. h.cullington@soton.ac.uk
Insights
UK children with hearing loss can now receive simultaneous or sequential bilateral cochlear implants, thanks to updated National Institute for Health and Clinical Excellence (NICE) guidelines. A multi-center audit is evaluating outcomes for these children.
Area of Science:
- Audiology
- Pediatric Medicine
- Public Health Policy
Background:
- Historically, UK public funding primarily supported unilateral cochlear implants for children.
- National Institute for Health and Clinical Excellence (NICE) guidelines revised in 2009 enabled bilateral cochlear implants for suitable children.
- NICE planned a review of these guidelines in 2011, necessitating data collection on bilateral implant outcomes.
Purpose of the Study:
- To conduct a multi-center audit evaluating the outcomes of simultaneous and sequential bilateral cochlear implants in children.
- To gather comprehensive data in preparation for the 2011 NICE guideline review.
- To assess various functional and quality-of-life measures in pediatric cochlear implant recipients.
Main Methods:
- A consortium of 13 UK cochlear implant centers collaborated on the multi-center audit.
- Data were collected from children receiving simultaneous or sequential bilateral cochlear implants at three time points: pre-implantation, 1 year post-implantation, and 2 years post-implantation.
- Evaluated measures included speech recognition (quiet/noise), localization, speech production, listening skills, vocabulary, parental perception, quality of life, and surgical complications.
Main Results:
- The audit has collected data from over 400 children past the 1-year post-implantation mark.
- Preliminary results are anticipated approximately one year after the 1-year data collection point.
- The study is ongoing, with 2-year post-implantation data yet to be fully analyzed.
Conclusions:
- The ongoing audit provides crucial data on the efficacy and safety of bilateral cochlear implantation in children.
- Findings will inform future NICE guidelines and clinical practice regarding pediatric cochlear implantation in the UK.
- The comprehensive data collection aims to support evidence-based decisions for improving hearing outcomes in children.
Abstract:
Prior to 2009, UK public funding was mainly only available for children to receive unilateral cochlear implants. In 2009, the National Institute for Health and Clinical Excellence (NICE) published guidance for cochlear implantation following their review. According to these guidelines, all suitable children are eligible to have simultaneous bilateral cochlear implants or a sequential bilateral cochlear implant if they had received the first before the guidelines were published. NICE stated that they would review this decision in 2011. In preparation for this review, 13 UK cochlear implant centres formed a consortium, and the decision was made to carry out a multi-centre audit. The audit involves collecting data from simultaneously and sequentially implanted children at three intervals: before bilateral cochlear implants or before the sequential implant, 1 year after bilateral implants, and 2 years after bilateral implants. The measures include localization, speech recognition in quiet and background noise, speech production, listening, vocabulary, parental perception, quality of life, and surgical data including complications. The audit has now passed the 1-year point, and data have been received on more than 400 children. Preliminary results will be available a year later.
Related Concept Videos
Pharmacokinetics in Pediatric Patients: Drug Excretion
Nursing Assessment of the Genitourinary System II: Inspection and Palpation
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption
